Megan Boston
Chief Financial Officer, Director · Benitec Biopharma Inc.
Individual
- 2024
- Nov 20, 2025
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Megan Boston files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- SUVRETTA CAPITAL MANAGEMENT, LLC - $22.44M in BNTC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Megan Boston?
Megan Boston is a corporate insider, tracked as Chief Financial Officer, Director of Benitec Biopharma Inc. (BNTC). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Megan Boston last file a Form 4?
The most recent primary Form 4 on record is dated 20 November 2025, one of 2 filings going back to 2024.